Celecoxib Enhances Susceptibility of Multidrug Resistant Cancer Cells to 17-Allylamino-17-demethoxy geldanamycin through Dual Induction of Apoptotic and Autophagic Cell Death
![]() |
Moon, Hyun-Jung
(Department of Biochemistry, Pusan National University School of Medicine)
Park, So-Young (Department of Biochemistry, Pusan National University School of Medicine) Lee, Su-Hoon (Department of Biochemistry, Pusan National University School of Medicine) Kang, Chi-Dug (Department of Biochemistry, Pusan National University School of Medicine) Kim, Sun-Hee (Department of Biochemistry, Pusan National University School of Medicine) |
1 | Huang, J. M., Sheard, M. A., Ji, L. Y., Sposto, R. and Keshelava, N. 2010. Combination of vorinostat and flavopiridol is selectively cytotoxic to multidrug-resistant neuroblastoma cell lines with mutant TP53. Mol. Cancer Ther. 9, 3289-3301. DOI |
2 | Kaewpiboon, C., Surapinit, S., Malilas, W., Moon, J., Phuwapraisirisan, P., Tip-Pyang, S., Johnston, R. N., Koh, S. S., Assavalapsakul, W. and Chung, Y. H. 2014. Feroniellin A-induced autophagy causes apoptosis in multidrug- resistant human A549 lung cancer cells. Int. J. Oncol. 44, 1233-1242. DOI |
3 | Kastan, M. B. and Berkovich, E. 2007. p53: a two-faced cancer gene. Nat. Cell Biol. 9, 489-491. DOI |
4 | Kim, H. B., Lee, S. H., Um, J. H., Oh, W. K., Kim, D. W., Kang, C. D. and Kim, S. H. 2015. Sensitization of multidrug-resistant human cancer cells to Hsp90 inhibitors by down-regulation of SIRT1. Oncotarget 6, 36202-36218. |
5 | Kroemer, G., Marino, G. and Levine, B. 2010. Autophagy and the integrated stress response. Mol. Cell. 40, 280-293. DOI |
6 | Li, Y. J., Lei, Y. H., Yao, N., Wang, C. R., Hu, N., Ye, W. C., Zhang, D. M. and Chen, Z. S. 2017. Autophagy and multidrug resistance in cancer. Chin. J. Cancer 36, 52. DOI |
7 | Lin, K., Rockliffe, N., Johnson, G. G., Sherrington, P. D. and Pettitt, A. R. 2008. Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells. Oncogene 27, 2445-2455. DOI |
8 | Liu, M., Li, C. M., Chen, Z. F., Ji, R., Guo, Q. H., Li, Q., Zhang, H. L. and Zhou, Y. N. 2014. Celecoxib regulates apoptosis and autophagy via the PI3K/Akt signaling pathway in SGC-7901 gastric cancer cells. Int. J. Mol. Med. 33, 1451-1458. DOI |
9 | Mori, M., Hitora, T., Nakamura, O., Yamagami, Y., Horie, R., Nishimura, H. and Yamamoto, T. 2015. Hsp90 inhibitor induces autophagy and apoptosis in osteosarcoma cells. Int. J. Oncol. 46, 47-54. DOI |
10 | Muller, P., Hrstka, R., Coomber, D., Lane, D. P. and Vojtesek, B. 2008. Chaperone-dependent stabilization and degradation of p53 mutants. Oncogene 27, 3371-3383. DOI |
11 | Piper, P. W. and Millson, S. H. 2011. Mechanisms of resistance to Hsp90 inhibitor drugs: a complex mosaic emerges. Pharmaceuticals (Basel) 4, 1400-1422. DOI |
12 | Nazim, U. M. D., Moon, J. H., Lee, J. H., Lee, Y. J., Seol, J. W., Eo, S. K., Lee, J. H. and Park, S. Y. 2016. Activation of autophagy flux by metformin downregulates cellular FLICE-like inhibitory protein and enhances TRAIL-induced apoptosis. Oncotarget 7, 23468-23481. |
13 | Neckers, L. and Workman, P. 2012. Hsp90 molecular chaperone inhibitors: Are we there yet? Clin. Cancer Res. 18, 64-76. DOI |
14 | Pan, Y. Z., Wang, X., Bai, H., Wang, C. B., Zhang, Q. and Xi, R. 2015. Autophagy in drug resistance of the multiple myeloma cell line RPMI8226 to doxorubicin. Genet. Mol. Res. 14, 5621-5629. DOI |
15 | Takara, K., Hayashi, R., Kokufu, M., Yamamoto, K., Kitada, N., Ohnishi, N. and Yokoyama, T. 2009. Effects of nonsteroidal anti-inflammatory drugs on the expression and function of P-Glycoprotein/MDR1 in Caco-2 cells. Drug Chem. Toxicol. 32, 332-337. DOI |
16 | Shimizu, S., Kanaseki, T., Mizushima, N., Mizuta, T., Arakawa-Kobayashi, S., Thompson, C. B. and Tsujimoto, Y. 2004. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat. Cell Biol. 6, 1221-1228. DOI |
17 | Shimizu, S., Yoshida, T., Tsujioka, M. and Arakawa, S. 2014. Autophagic cell death and cancer. Int. J. Mol. Sci. 15, 3145-3153. DOI |
18 | Sui, X., Chen, R., Wang, Z., Huang, Z., Kong, N., Zhang, M., Han, W., Lou, F., Yang, J., Zhang, Q., Wang, X., He, C. and Pan, H. 2013. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 4, e838. DOI |
19 | Wan, X. M., Zheng, F., Zhang, L., Miao, Y. Y., Man, N. and Wen, L. P. 2011. Autophagy-mediated chemosensitization by cysteamine in cancer cells. Int. J. Cancer 129, 1087-1095. DOI |
20 | Yu, C., Li, W. B., Liu, J. B., Lu, J. W. and Feng, J. F. 2018. Autophagy: novel applications of nonsteroidal anti-inflammatory drugs for primary cancer. Cancer Med. 7, 471-484. DOI |
21 | Helgason, G. V., Karvela, M. and Holyoake, T. L.2011. Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML. Blood 118, 2035-2043. DOI |
22 | Yoshii, S. R. and Mizushima, N. 2017. Monitoring and measuring autophagy. Int. J. Mol. Sci. 18, 1865. DOI |
23 | Chen, N. and Karantza, V. 2011. Autophagy as a therapeutic target in cancer. Cancer Bio. Thr. 11, 157-168. DOI |
24 | Cheng, J., Chen, J., Xie, B. and Wei, H. L. 2013. Acquired multidrug resistance in human K562/ADM cells is associated with enhanced autophagy. Toxicol. Mech. Methods 23, 678-683. DOI |
25 | Choudhury, S., Kolukula, V. K., Preet, A., Albanese, C. and Avantaggiati, M. L. 2013. Dissecting the pathways that destabilize mutant p53 The proteasome or autophagy? Cell Cycle 12, 1022-1029. DOI |
26 | Garufi, A,, Pucci, D., D'Orazi, V., Cirone, M., Bossi, G., Avantaggiati, M. L. and D'Orazi, G. 2014. Degradation of mutant p53H175 protein by Zn(II) through autophagy. Cell Death Dis. 5, e1271. DOI |
![]() |